CURIS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CURIS, INC. stock issued during period, value, other for fiscal 2021 was $135.00K, a 132.76% increase from fiscal 2020.
- CURIS, INC. stock issued during period, value, other for fiscal 2020 was $58.00K, a 14.71% decline from fiscal 2019.
- CURIS, INC. stock issued during period, value, other for fiscal 2019 was $68.00K, a 52.45% decline from fiscal 2018.
- CURIS, INC. stock issued during period, value, other for fiscal 2018 was $143.00K, a 87.79% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-12-31 | $135.00K 10-K · filed 2022-02-24 | |
| 2020-12-31 | $58.00K 10-K · filed 2022-02-24 | |
| 2019-12-31 | $68.00K 10-K · filed 2022-02-24 | |
| 2018-12-31 | $143.00K 10-K · filed 2020-03-19 | |
| 2017-12-31 | $1.17M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $2.91M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $1.21M 10-K · filed 2018-03-08 | |
| 2014-12-31 | $283.00K 10-K · filed 2017-03-09 | |
| 2013-12-31 | $20.88M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $6.24M 10-K · filed 2015-02-24 | |
| 2011-12-31 | $2.46M 10-K · filed 2014-03-13 | |
| 2010-12-31 | $349.58K 10-K · filed 2013-03-13 | |
| 2009-12-31 | $798.14K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |